More from Investing
The shares have weakened significantly the past 12 months.
Small-cap biotech Marker Therapeutics and online appliance seller 1847 Goedeker have been beaten down lately but offer hope for bouncing back.
The technical signals are indicating that the stock of the Western apparel retailer may be running out of steam after a long run higher this year.
I think I'm likely to remain 'skinny' for now, and prioritize trading over investment at least for the next 10 business days or so.
Omicron may not be as deadly as feared, but inflation, growth, technical conditions, and central bank uncertainties continue to pressure the market.